The stock soared 6.98 per cent to Rs 565 on BSE.
On NSE, shares of the company jumped 7.35 per cent to Rs 565.
"Cipla reported in line results on both revenue as well as PAT front," Kotak Securities said in a note.
Drug major Cipla yesterday reported a 34.74 per cent slide in consolidated net profit to Rs 354.34 crore for the second quarter ended September 2016, mainly on account of increase in expenditure.
Consolidated total income from operations, however, rose to Rs 3,751.02 crore for the quarter under review as against Rs 3,455.09 crore a year earlier.
Disclaimer: No Business Standard Journalist was involved in creation of this content
